Sep 03, 2019
Oramed to Present at Three Upcoming Conferences
Jul 10, 2019
Oramed to Present at World Diabetes Congress
Jul 02, 2019
Oramed Announces Xiaoming Gao Joins Board of Directors
Jun 18, 2019
Oramed Provides Clinical Update with Meaningful Data Expected by Year-End
Jun 03, 2019
Oramed to Present at BIO International Convention
May 21, 2019
Oramed Completes Patient Recruitment of Phase IIb HbA1c Trial for Oral Insulin Capsule ORMD-0801
Apr 29, 2019
Oramed to Present at ThinkEquity Conference
Apr 11, 2019
Oramed to Present at 3rd Annual Clinical Trials Summit
Apr 04, 2019
Oramed Patent Allowed in the U.S. for Oral Exenatide
Apr 03, 2019
Oramed to Present at H.C. Wainwright Global Life Sciences Conference
Mar 28, 2019
Oramed Patent Allowed in the U.S. for Key Aspect of Its Oral Delivery Technology
Mar 26, 2019
Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed's Oral Insulin Capsules
Feb 13, 2019
Frost & Sullivan Publishes Q1 2019 Update on Oramed Pharmaceuticals Inc.
Feb 06, 2019
Oramed to Present at BIO CEO & Investor Conference
Jan 22, 2019
Oramed Initiates Phase I Oral GLP-1 Study Under IND
Jan 15, 2019
Oramed Pharmaceuticals' CEO Letter to Shareholders
Jan 09, 2019
Oramed Receives Additional $3 Million Milestone Payment from HTIT
Nov 13, 2018
Oramed Completes Over 50% Randomization in Its Pivotal 90-Day Clinical Study
Nov 05, 2018
Oramed to Present at the Tides Europe 2018 Conference
Oct 23, 2018
Oramed to Present at Cardiometabolic Health Congress